TrialBritish journal of cancer2000

Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings.

E Tartour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.